2. CONTRIBUTORS
• DR. JYOTI AGARWAL
• DR. JYOTI BHASKAR
• DR. SHARDA JAIN

3. D - DEATH
I - IS
C - COMING
DIC is an important contributor to
maternal mortality and morbidity

4. What is DIC ?
•DIC is a massive activation of
the coagulation system leading
to multiple clot formation
throughout the body.
•As a result there is rapid
consumption of clotting
factors which leads to
bleeding.
•So it is a paradoxical
condition characterised by
both thrombosis &
haemorrhage.

5. • DIC is a red flag for a severe
underlying disease
• DIC is never a primary diagnosis
• It is always a secondary diagnosis

6. INTRINSIC PATHWAY EXTRINSIC PATHWAY
XII XIIa VIIa
XIa
IXa
Ca
VIIIa
Xa (COMMON PATHWAY)
Prothrombin Thrombin
Plasmin
Fibrinogen Fibrin D-dimer
Plasmin
FDPs

7. Coagulation is always the initial
event
A delicate
balance exists
between
coagulation
mechanism &
fibrinolytic
system.

8. TRIGGER MECHANISMS OF DIC
DURING PREGNANCY
Pre- eclampsia
• Hypovolaemia
• Septicaemia
• Large foetomaternal
bleed
• Incompatible blood
transfusion
• Abruptio placentae
• Amniotic fluid
embolism
• Retained dead foetus
• Intrauterine sepsis
• H. mole
• Placenta accreta
• Abortion induced by
hypertonic fluids.

9. CLINICAL MANIFESTATIONS
• Bleeding from multiple sites ( most common )
( either oozing or frank bleeding)
• Renal dysfunction
• Hepatic dysfunction
• Respiratory dysfunction
• Shock and death

10. Diagonosis of DIC
• No single test diagnoses DIC
• Clinical picture leads to diagnosis of
DIC

11. Bed side Tests
• Clot Observation Test (CT)- if a firm clot
forms within 10 mins it is unlikely that pt has
DIC and that fibrinogen levels are normal.
• Clot Retraction Time-if the clot retracts well
by end of one hour it means the platelets are
adequate
• An unstable or fragile clot indicates presence
of FDPs in blood.

12. Lab parameters usually
associated with DIC are
Thrombocytopenia
Develops due to activation of clotting
system and consumption by clot formation
Sensitive but not specific

13. Fibrinogen degradation products
and D- Dimer
• It is the most sensitive test for DIC. (85-100%)
• It is unlikely to be DIC if FDP’s levels are normal.
• FDPs are metabolized in liver and kidney.
• Hepatic or renal dysfunction may lead to falsely
elevated levels of FDPs

14. PT & PTT
• PTT measures intrinsic pathway
• PT measures extrinsic pathway
• PT and PTT prolonged in 50-60% of DIC
cases
Can use PT and PTT to
monitor DIC

15. Fibrinogen
• Classically use to diagnose and
monitor DIC.
• Most cases not very helpful.
• Sensitivity of a low fibrinogen level for
the diagnosis of DIC is only 28%

16. Fibrinogen
• Fibrinogen is an acute-phase reactant so
may be falsely normal in DIC.
• Hypofibrinogenemia is detected only in very
severe cases of DIC.
• The blood fibrinogen level of 100mgm/100ml
is considered to be the critical level

17. Schistocytes (Fragmented RBCs)
•Fragmented red blood cells rarely constitute
>10% of the red cells.
•Neither sensitive nor specific to
DIC.

18. Antithrombin & Protein C
• Antithrombin and protein C are often
reduced in DIC.
• Have shown to have both diagnostic and
prognostic significance .

19. DIC Scoring System
International Society
for thrombosis and
Haemostasis ( ISTH )

20. 5 step diagnostic algorithm
Sensitivity 91%
Specificity 97%

21. ISTH Scoring System
Prerequisite
Does the patient have an
underlying disorder known to
be associated with overt DIC ?

22. NONO

23. Do NOT use
this algorithm.

24. YESYES

25. Coagulation Tests
• Prothrombin time
• Platelet count
• Fibrinogen levels
• Fibrin related marker (FDPs, D-dimer)

26. Score Test Results

27. Prothrombin Time
<3 sec = 0
>3 but <6 sec = 1
>6 sec = 2

28. Platelet Count
> 100,000 /cumm = 0
50-100,000 /cumm = 1
< 50,000 /cumm = 2

29. Fibrinogen Level
•> 1 g / l = 0
•< 1 g / l = 1

30. Fibrin Marker (e.g. D-dimer, FDPs)
• No increase = 0
• Moderate increase = 2
• Strong increase = 3

31. Calculate score
• > or = to 5 compatible with overt DIC
• < 5 suggestive for non - overt DIC

32. PROTOCOL OF MANAGEMENT
• Maintenance of blood pressure and oxygenation
• Maintenance of blood volume (crystalloids,
albumin, plasma expanders).
• Blood Component therapy
• Treatment of underlying etiology of DIC

33. • Management of blood volume includes
prompt & adequate fluid replacement to prevent
renal shutdown.
• Crystalloids (Ringer lactate) / Haemaccel
• Colloids X
Whatever fluid is used, it only acts as a stop gap
until suitable blood component therapy is
available

34. Blood component therapy
• Fresh frozen plasma
• Cryoprecipitate
• Platelets
• Packed red blood cells

35. Packed red blood cells
• Are most effective to improve oxygen carrying
capacity
• Each unit contains about 300 ml ( 250 ml RBC &
50 ml plasma)
• One unit of PRBC raises the Hb by 1 gm/dl and
PCV by 3 %.

36. Platelet concentrates
• Platelets should be given rapidly over 10 mins.
• One unit raises the count between 5000 –
10,000/ ml.
• Dose is = one unit / 10 kg.
• single donor concentrates are preferred as the
antigenic risk is low.
• Platelets count can be assessed 10 – 60 mins
after transfusion.

37. Fresh Frozen Plasma (FFP)
• Provides both volume & coagulation factor
replacement.
• One unit of FFP (250 ml) raises fibrinogen by
5 – 10 mgm /dl.
• Dose 10 – 15 ml/ kg or one bag / 10 kg

38. Cryoprecipitate
• It is rich in fibrinogen so its use is indicated if blood
fibrinogen levels are < 1 gm / L.
• One unit increases the fibrinogen level by 5- 10
mg/dl.
• Dose is 1 unit/ 5 kg.
• No. of bags required is =0.2 x body weight in kg.

39. The main therapeutic goal is
to maintain
• Hb > 8 gm / L
• Platelet count > 75 ,000 / cumm
• Prothrombin time < 1.5 times the normal
• Activated prothrombin time < 1.5
• Fibrinogen > 1.0 gm / L

40. Treatment of the
underlying condition

41. PLACENTAL ABRUPTION--
• The severity of DIC is directly related to
time interval between the placental
separation and delivery
• Management thus includes emptying the
uterus as soon as possible

42. PRE ECLAMPSIA- ECCLAMPSIA
SYNDROME
• Majority of women with pre-ecclampsia have
sub-clinical consumptive coagulopathy.
• Frank DIC is seen when there is associated
placental abruption or HELLP syndrome.
Immediate delivery is recommended

43. AMNIOTIC FLUID EMBOLISM
• Carries high maternal mortality (80%)
• Treatment is mainly supportive as there is no
proven effective therapy.
• Heparin may be considered (80-100 units /kg s/c
4-6 hly )

44. INTRAUTERINE FETAL DEMISE
• Goal: to raise fibrinogen level to 200-300
mg/dL before termination of pregnancy.
• Heparin may be considered for chronic DIC
associated with IUD

45. SEPSIS
• Intensive antibiotic therapy followed by
evacuation of uterine contents.
• Prompt restoration and maintenance of
circulation.
• Removal of septic focus

46. To conclude
The only proven treatment of DIC
Stop the triggering
process .

47. CRITICAL CARE
CAN MAKE A GREAT DIFFERENCE
ALERT MIND !
TIMELY INTERVENTION !
AGGRESSIVE MANAGEMENT !

48. THANK
YOU

49. Normal values of blood
coagulation profile
Prothrombin time(11-16s)-Extr.pathway
• PTT-(30-45s) –Intrinsic pathway
• Thrombin time (TT) 10-15s
• S. Fibrinogen- (300-600mg%)
• Platelets (1.5-3.0L)
• D-dimer (<0.5mg/L) 0-200mgm/ml
Fibrin degradation products (10µ/dl) 0-5 microgm/ml